Cardiometabolic syndrome (CMS) is a complex interplay of metabolic dysregulation, cardiovascular disease and diabetes risk factors. It encompasses obesity, insulin resistance, dyslipidaemia, hyperuricemia, and hypertension, with obesity triggering metabolic disturbances. The global prevalence of CMS is driven by rising obesity rates and sedentary lifestyles.

The metrics on the metabolic health of Australians are concerning and suggest an emerging crisis:

• 67% of Australian adults and 25% of Australian children are overweight or obese
• 1 in 4 Australians have NAFLD
• 1 in 20 Australians (or 1.3 million) Australians have type 2 diabetes
• 97,000 Australians are estimated to have bariatric surgery in 2024
• 5 million Australians take statins to manage cholesterol
• This one-day event explores the key issues and latest research on cardiometabolic disorders with a focus on evidence-based, effective dietary, nutritional and lifestyle approaches to treatment.

The information will be presented by leading clinicians and academics in this field – Dr Ross Walker, Dr Michelle Woolhouse, Dr Elizabeth Steels, Dr Brad McEwen, Dr Arun Dhir and Rebecca Edwards.

Restoration of metabolic health is possible with the right information, tools and approaches.

You will learn how to assess, prevent, manage and restore metabolic health

KEY TOPICS INCLUDE:

• Continual glucose monitoring – understand how to interpret the metrics of this powerful behaviour modification tool
• Protocols for effective blood sugar management
• The latest research on statins, cholesterol and the microbiome
• Nutritional strategies to support post-surgery deficiencies in bariatric patients
• The misconceptions and myths of cholesterol and an evidence-based approach to its effective management
• The key drivers of NAFLD and effective management strategies
• GLP-1 agonists: the promise and the risks that accompany these medicines

FxMed is proud to be a sponsor of this event.